Top

Orphanet Journal of Rare Diseases

Published in:

Open Access 01-12-2024 | Systemic Lupus Erythematosus | Research

Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis

Authors: Josep Darba, Meritxell Ascanio, Ainoa Agüera

Published in: Orphanet Journal of Rare Diseases | Issue 1/2024

Abstract

Background

This study aimed to assess the comorbidity profile, use of healthcare resources and medical costs of patients with systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) treated at the hospital level in Spain.

Methods

Admission records of patients with SLE and CLE that were registered between January 2016 and December 2020 were obtained from a Spanish hospital discharge database and analyzed in a retrospective multicenter study.

Results

329 patients met the criteria; 64.44% were female and 35.56% were male, with a median age of 54.65 years. Mean Charlson comorbidity index (CCI) was 2.75 in the index admission. 31.61% of the patients suffered essential hypertension, 21.96% suffered asthma and 19.76% suffered hyperlipidemia. Mortality rate was 3.95%. The most common medical procedure was heart ultrasound (19.45%) and introduction in peripheral vein of anti-inflammatory with a percutaneous approach (17.93%). Mean admission cost was €6355.99.

Conclusions

Lupus patients showed a higher incidence and prevalence in the female population, with associated cardiac diseases as the main secondary conditions.

Gurevitz SL, Snyder JA, Wessel EK, Frey J, Williamson BA. Clinical review systemic lupus erythematosus: a review of the disease and treatment options. 2013.

Arévalo-Bermúdez MdelP, Paradela S, Balboa-Barreiro V, Fonseca E. Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain. Lupus. 2020;29(9):1021–1030. https://doi.org/10.1177/0961203320930094

Tamirou F et al. Systemic lupus erythematosus: state of the art on clinical practice guidelines. RMD Open. 2018;4(2). BMJ Publishing Group.https://doi.org/10.1136/rmdopen-2018-000793

Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1:6. https://doi.org/10.1186/1750-1172-1-6. Published 2006 Mar 27.CrossRefPubMedPubMedCentral

Sabio JM. Systemic lupus erythematosus today. Med Clin (Barc). Feb. 2016;146(4):160–2. https://doi.org/10.1016/j.medcli.2015.08.001

Alonso MD, et al. Systemic lupus erythematosus in Northwestern Spain: a 20-year epidemiologic study. Medicine. Sep. 2011;90(5):350–8. https://doi.org/10.1097/MD.0b013e31822edf7f

Ruiz E, Ramalle-Gómara E, Elena Á, Quiñones C, Alonso V, Posada M. Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. Lupus. 2014;23(4):431–435. https://doi.org/10.1177/0961203313517015

Janssens P, Arnaud L, Galicier L et al. Lupus enteritis: from clinical findings to therapeutic management. Orphanet J Rare Dis. 2013;8:67. Published 2013 May 3. https://doi.org/10.1186/1750-1172-8-67

Yue C, Su J, Fan X et al. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study. Orphanet J Rare Dis. 2020;15(1):225. Published 2020 Aug 28. https://doi.org/10.1186/s13023-020-01510-9

10.

Aringer M et al. Sep., 2019 European league against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. https://doi.org/10.1136/annrheumdis-2018-214819

11.

Fernandez-Nebro A, et al. Cardiovascular events in systemic lupus erythematosus: a nationwide study in Spain from the RELESSER Registry. Med (United States). 2015;94(29). https://doi.org/10.1097/MD.0000000000001183

12.

Jiménez S, Cervera R, Font J, Ingelmo M. Epidemiology of SLE 3 the epidemiology of systemic Lupus Erythematosus. 2003.

13.

Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308–18. https://doi.org/10.1191/0961203306lu2305xxCrossRefPubMed

14.

Cortés Verdú R et al. Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Rheumatology (United Kingdom). 2020;59(9):2556–2562. https://doi.org/10.1093/rheumatology/kez668

15.

Hernández-Rodríguez JC, Durán-Romero AJ, Muñoz-Jiménez A, Conejo-Mir J, Pereyra-Rodríguez JJ. Trends in mortality from lupus in Spain from 1980 to 2018. Lupus. 2020;29(13):1719–1726. https://doi.org/10.1177/0961203320952864

16.

Carneiro AC, Ruiz MM, Freitas S, Isenberg D. Comparison of three classification criteria sets for systemic lupus erythematosus: a study looking at links to outcome and mortality. Arthritis Care Res (Hoboken). 2020;72(11):1611–1614. https://doi.org/10.1002/acr.24061

17.

Spanish Ministry of Health. Hospital discharge records in the national health System. Spanish Ministry of Health; 2019. [cited 2023 March 17]. https://www.sanidad.gob.es/estadEstudios/sanidadDatos/home.htm

18.

Kolmogorov–Smirnov Test. In: The concise encyclopedia of statistics. Springer, New York, NY. 2008. https://doi.org/10.1007/978-0-387-32833-1_214

19.

Sundjaja JH, Shrestha R, Krishan K, McNemar, Mann-Whitney U, Tests. [Updated 2023 Jul 17]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560699/

20.

Kruskal-Wallis Test. In: The concise encyclopedia of statistics. Springer, New York, NY. 2008. https://doi.org/10.1007/978-0-387-32833-1_216

21.

Manning SE, Ku H-C, Dluzen DF, Xing C, Zhou Z. A nonparametric alternative to the Cochran-Armitage trend test in genetic case-control association studies: the Jonckheere-Terpstra trend test. PLoS ONE. 2023;18(2):e0280809. https://doi.org/10.1371/journal.pone.0280809CrossRefPubMedPubMedCentral

22.

Bruce IN et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic lupus international collaborating clinics (SLICC) inception cohort. Ann Rheum Dis. 2015;74(9):1706–1713. https://doi.org/10.1136/annrheumdis-2013-205171

23.

Cervera R, Khamashta MA, Hughes GRV. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus. 2009;18(10):869–74. https://doi.org/10.1177/0961203309106831CrossRefPubMed

24.

Johnson SR et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020;79(10):1333–1339. https://doi.org/10.1136/annrheumdis-2020-217162

25.

Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immu. 2017;13(8):799–814. Taylor and Francis Ltd. https://doi.org/10.1080/1744666X.2017.1327352

26.

Narváez J, et al. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther. Dec. 2018;20(1). https://doi.org/10.1186/s13075-018-1776-8

27.

Fatoye F, Gebrye T, Svenson LW. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada. PLoS ONE. 2021;16(5):e0251409. https://doi.org/10.1371/journal.pone.0251409CrossRefPubMedPubMedCentral

28.

Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40(1):37–47. https://doi.org/10.1093/rheumatology/40.1.37CrossRefPubMed

29.

Clarke AE, Petri M, Manzi S, et al. The systemic lupus erythematosus tri-nation study: absence of a link between health resource use and health outcome. Rheumatology (Oxford). 2004;43(8):1016–24. https://doi.org/10.1093/rheumatology/keh229CrossRefPubMed

30.

Huscher D, Merkesdal S, Thiele K, et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65(9):1175–83. https://doi.org/10.1136/ard.2005.046367CrossRefPubMedPubMedCentral

Title: Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis
Authors: Josep Darba
Meritxell Ascanio
Ainoa Agüera
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Systemic Lupus Erythematosus
Lupus Erythematosus
Published in: Orphanet Journal of Rare Diseases / Issue 1/2024
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-024-03077-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Lymphatic drainage of sinonasal malignancies and the role of sentinel node biopsies

Lived experiences of genetic diagnosis for rare disease patients: a qualitative interview study

Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease

Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease

Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center

Genotype-phenotype associations in microtia: a systematic review